Concomitant NovaSure Endometrial Ablation and Essure Tubal Sterilization: A Review of 100 Cases
|
|
- Branden Lee
- 6 years ago
- Views:
Transcription
1 Concomitant NovaSure Endometrial Ablation and Essure Tubal Sterilization: A Review of 100 Cases Carmen N. Mircea, MD, 1 Ciaran Goojha, MD, 1 John A. Thiel, MD 1,2 1 Department of Obstetrics and Gynecology, University of Saskatchewan, Saskatoon SK 2 Department of Obstetrics and Gynecology, Regina Qu Appelle Health Region, Regina SK Abstract Objective: To assess the success rate, complications, and technical difficulties of concomitant NovaSure radiofrequency global endometrial ablation (NS-GEA) and Essure hysteroscopic sterilization (EHS). Methods: We conducted a retrospective descriptive study of 100 women undergoing concomitant NS-GEA and EHS for abnormal uterine bleeding. The combined procedure was completed using conscious sedation, in an outpatient setting. Patients were asked to return three months post procedure to have proper microinsert positioning confirmed by hysterosalpingogram, ultrasound, and/or pelvic radiograph. Results: An average of five micro-inserts were left trailing into the endometrial cavity. The mean duration of the procedure was on average 17.1 minutes. Eighty-seven patients returned for follow-up. The combined procedure was successful in 80 of these 87 patients (92%) and not successful in seven patients (8%). To improve visualization of the tubal ostia, 25 patients had suction curettage after NS-GEA, with no significant increase in the procedure time (P = 0.927). Technical difficulties included impaired visualization of the tubal ostia (7.4%), difficulty in visualizing or counting micro-inserts after placement (3.2%), and resistance to micro-insert placement (3.2%). The procedure complications were intrauterine synechiae (5.7%), endometritis (2.3%), pain that required an emergency room visit (2.3%), and migration of micro-inserts with or without perforation (4.6%). Conclusion: Concomitant NS-GEA and EHS is a safe and efficient method of providing treatment for abnormal uterine bleeding and permanent female sterilization. The combined procedure can be safely moved from the operating theatre to an outpatient setting, completely independent of anaesthesia and day surgery services. Suction curettage should be considered before EHS. A small proportion of patients may develop post-procedure intrauterine synechiae that impaired the ability to document tubal occlusion by hysterosalpingogram. Key Words: NovaSure radiofrequency global endometrial ablation, Essure hysteroscopic sterilization, abnormal uterine bleeding, intrauterine synechia Competing Interests: See Acknowledgements. Received on November 20, 2010 Accepted on December 13, 2010 Résumé Objectif : Évaluer le taux de réussite, les complications et les difficultés techniques de la tenue concomitante des interventions NovaSure radiofrequency global endometrial ablation (NS-GEA) et Essure hysteroscopic sterilization (EHS). Méthodes : Nous avons mené une étude descriptive rétrospective portant sur 100 femmes qui se soumettaient à des interventions NS-GEA et EHS concomitantes visant un saignement utérin anormal. L intervention combinée a été menée sous sédation consciente, dans une unité de soins ambulatoires. On avait demandé aux patientes de revenir, trois mois à la suite de l intervention, pour la tenue d un hystérosalpingogramme, d une échographie et/ou d une radiographie pelvienne visant à confirmer le positionnement adéquat du micro-insert. Résultats : En moyenne, cinq micro-inserts ont été laissés dans la cavité endométriale. La durée moyenne de l intervention a été de 17,1 minutes. Quatre-vingt sept patientes se sont présentées pour le suivi. L intervention combinée a été couronnée de succès chez 80 de ces 87 patients (92 %) et s est soldée en échec chez sept patientes (8 %). Pour améliorer la visualisation des orifices tubaires, 25 patientes ont subi un curetage par aspiration à la suite de l intervention NS-GEA, sans que cela n occasionne de hausse significative de la durée d intervention (P = 0,927). Parmi les difficultés techniques, on trouvait la difficulté de visualiser les orifices tubaires (7,4 %), la difficulté de visualiser ou de dénombrer les micro-inserts à la suite du positionnement (3,2 %) et la résistance au positionnement des micro-inserts (3,2 %). Parmi les complications de l intervention, on trouvait les synéchies intra-utérines (5,7 %), l endométrite (2,3 %), la douleur nécessitant une consultation en salle d urgence (2,3 %) et la migration des micro-inserts avec ou sans perforation (4,6 %). Conclusion : La tenue concomitante des interventions NS-GEA et EHS constitue un moyen sûr et efficace d assurer la prise en charge du saignement utérin anormal et de procéder à une stérilisation permanente. L intervention combinée peut être menée en toute sûreté au sein d une unité de soins ambulatoires (plutôt qu en salle d opération), de façon tout à fait indépendante des services d anesthésie et de chirurgie d un jour. La tenue d un curetage par aspiration devrait être envisagée avant de procéder à l intervention EHS. Une faible proportion de patientes peut en venir à voir apparaître, à la suite de l intervention, des synéchies intra-utérines nuisant à la capacité de documenter l occlusion tubaire par hystérosalpingogramme. J Obstet Gynaecol Can 2011;33(4): APRIL JOGC AVRIL
2 INTRODUCTION Abnormal uterine bleeding is a common gynaecological problem that has significant impact on a woman s quality of life and health care costs. Traditionally, the surgical treatment for abnormal uterine bleeding has been hysterectomy. 1,2 A safe and effective minimally invasive surgical alternative to hysterectomy has been found in NovaSure global endometrial ablation. 3 Endometrial ablation is not a sterilizing procedure, and pregnancy after ablation may be associated with severe adverse events for the fetus and mother such as miscarriage, abnormal placentation, intrauterine growth restriction, uterine rupture or preterm birth. 4 7 Reliable contraception or permanent sterilization should therefore be offered to women of childbearing age undergoing the procedure. Since both GEA and Essure hysteroscopic tubal sterilization have been independently proven to be safe and efficient in controlling bleeding and providing reliable contraception, respectively, combining these two methods is an ideal solution. 3,8 10 Moreover, the cost-effectiveness of combining these two procedures may be significant. Indeed, performing concomitant NS-GEA and EHS has been shown to be effective management for women with abnormal uterine bleeding requiring post- NS-GEA permanent sterilization. 11,12 However, previous studies have been based on small numbers of patients. There are no current restrictions in Canada regarding the performance of concomitant global ablation and Essure micro-insert placement. Because we are able to use ultrasound as a follow-up to assess micro-insert position, 13 the potential for difficulty in interpreting the post-insertion hysterosalpingogram is not a concern. In the present study, we describe our five-year experience of performing 100 concomitant NS-GEA and EHS procedures, 98 of which were performed in an outpatient, ambulatory setting. This is the first study to describe the feasibility of concomitant NS-GEA and EHS procedure in an outpatient, ambulatory setting, completely independent from the operating room and anaesthesia services. MATERIALS AND METHODS We conducted a retrospective descriptive study of 100 women who were scheduled to have concomitant NS-GEA and EHS performed between July 2004 and September ABBREVIATIONS EHS Essure hysteroscopic tubal sterilization GEA global endometrial ablation NS-GEA NovaSure global endometrial ablation These women were referred to our clinic because of abnormal uterine bleeding. They were evaluated by one physician (J.A.T.) and management options were discussed. Patients elected to undergo NS-GEA and therefore required proper counselling regarding a permanent and reliable contraception method. After discussion of the options for permanent contraception, the patients opted to undergo EHS. Full investigation of the abnormal uterine bleeding (including endometrial biopsy and pelvic ultrasound) was carried out to rule out contraindications to either NS-GEA or EHS. Informed consent was obtained from all patients. Procedures were performed at various times in the menstrual cycle. No routine pre-treatment of the endometrium was carried out. Most of the patients underwent the concomitant procedures in the Women s Heath Centre, an outpatient department at the Regina General Hospital, not in the operating room, and did not require monitored anaesthesia care. Only two cases were carried out in the operating room. Specialized nursing staff received the patients and explained the procedure. The analgesia consisted of a combination of intravenous midazolam (1 to 2 mg) and fentanyl (2 μg/kg), and doses were titrated according to the patient s level of discomfort. The clinical status of patients (blood pressure, heart rate, and oxygen saturation) was closely monitored by the bedside nurse, and additional analgesia and/or sedation was given if necessary. Paracervical nerve block was induced using lidocaine 1%. Hysteroscopy was initially performed using a 5.5 mm single channel continuous flow hysteroscope and a 2.7 mm lens (Circon AMCI, Toronto, ON) and using normal saline as the distension medium. The tubal ostia were identified and, after appropriate dilatation of the cervix, NS-GEA was performed. Twenty-five patients had suction curettage with no.8 suction curette after endometrial ablation in order to improve visualization of the tubal ostia. The hysteroscope was reinserted and, after inspection of the uterine cavity and localization of the tubal ostia, Essure micro-inserts were placed according to the manufacturer s guidelines. After completion of the procedure, patients were transferred to the recovery area. Oral analgesia and antiemetic medication were provided as needed. We used single drug analgesia or combinations of ibuprofen, acetaminophen, acetaminophen with codeine, and promethazine. Patients were discharged from the ambulatory setting on the same day after the effects of conscious sedation had passed and patients were stable and comfortable. 362 APRIL JOGC AVRIL 2011
3 Concomitant NovaSure Endometrial Ablation and Essure Tubal Sterilization: A Review of 100 Cases Flow of study participants Patients were instructed to use a reliable contraceptive method for three months after the procedure, and office staff arranged appointments for the three-month followup to confirm correct placement of the micro-inserts using hysterosalpingography, conventional and/or 3-D ultrasound, or pelvic X-ray The results of these investigations were reviewed by a radiologist, and the position of the micro-inserts was deemed to be appropriate, not appropriate, or unsure. In case of uncertainty, a second confirmatory test (hysterosalpingogram or ultrasound) was performed. All data were collected by retrospective chart review. The population s demographics, the time and details of the procedure, and medication dosage were characterized using descriptive statistics. Mann-Whitney test was used to assess the time difference between procedures in which suction curettage was performed and those in which it was not performed. Ethics approval for the study was provided by the Ethics Review Board of Regina Qu Appelle Health Region. RESULTS The study flow chart is shown in the Figure. Six patients were excluded from the analysis because follow-up medical records could not be retrieved. The remaining 94 patients included in the study had a mean age of 39.5 ± 4.8 years (95% CI 38.5 to 40.5). The median parity was 2 (range 0 to 5), and mean body mass index was 29.2 ± 7.1 kg/m² (95% CI 27.7 to 30.7). APRIL JOGC AVRIL
4 Procedure time, NovaSure and Essure parameters Mean, SD (95% CI) Mean total procedure time (95% CI), min 17.1 ± 5.9 (15.9 to 18.3) NovaSure ablation, cm Mean cavity length (95% CI) 5.2 ± 0.4 (5.1 to 5.3) Mean cavity width (95% CI) 3.7 ± 0.7 (3.5 to 3.8) Essure micro-inserts, n Mean, Micro-inserts on left side (95% CI) 4.5 ± 2.2 (4.0 to 4.9) Mean, Micro-inserts on right side (95% CI) 4.9 ± 3.0 (4.3 to 5.5) Conscious sedation was used in 92 of 94 patients (98%); two patients (2 %) had the procedure performed in the operating room under general anaesthesia. Intravenous midazolam and fentanyl was used for 87% of patients (81/93). In 11% of patients (10/93), a combination of diazepam and fentanyl was used for analgesia. The mean doses of IV midazolam, fentanyl, and diazepam were 1.2 ± 0.6 mg (95% CI 1.1 to 1.3), ± 44.5 μg (95% CI to 177.9), and 3.2 ± 1.2 mg (95% CI 2.4 to 4.1), respectively. Technical difficulties occurred in 14.9% of patients (14/94) during the procedure and consisted of impaired visualization of the tubal ostia (7/94; 7.4%), difficulty in visualizing and counting micro-inserts after placement (3/94; 3.2%), or resistance to micro-insert placement (3/94; 3.2%). In one case (1.1%) the Essure procedure could not be completed because of patient discomfort. Since only endometrial ablation was performed, and not concomitant NS-GEA and EHS, this case was removed from analysis and the remaining 93 patients were further analyzed (Figure). Total procedure time and procedure variables are summarized in the Table. Twenty-five of the 93 patients (27%) had suction curettage performed after NS-GEA to improve visualization of the tubal ostia. No significant increase in the duration of the procedure was noted in the patients who had suction curettage performed (16 minutes; range 10 to 33) compared with the non-suction curettage group (15 minutes; range 7 to 36) (P = 0.927). Post-procedure analgesia consisted of acetaminophen 650 mg (in 18.4% of patients), ibuprofen 400 mg (28.2%), oral combinations of acetaminophen and ibuprofen (32.6%), or acetaminophen with codeine and ibuprofen (2.2%). Seven patients (7.7%) received various combinations of acetaminophen, ibuprofen, promethazine, and acetaminophen with codeine. No post-procedure analgesia was required in 10.9% of patients. Eighty-seven of the 93 patients (93.5%) presented for the three-month confirmation follow-up of the Essure micro-insert placement. Five (5.4%) patients failed to return for the follow-up, while one patient (1.1%) underwent hysterectomy before the time of the follow-up and thus did not require imaging. This patient requested total laparoscopic hysterectomy for chronic pelvic pain secondary to endometriosis. Essure micro-inserts were found to be properly positioned on assessment of the gross pathology of the specimen. During follow-up, bilateral tubal occlusion and/or proper micro-insert positioning was demonstrated in 80 of the returning 87 patients (92%) through hysterosalpingography, pelvic ultrasound and/or pelvic X-ray. The criteria for proper positioning of Essure micro-inserts were not met in the remaining seven patients (8.0%). Six patients (6.9%) showed unilateral tubal occlusion only, and in one case (1.1%) both micro-inserts were displaced into the uterine cavity. Only one of the 25 patients who had suction curettage after NS-GEA had improper micro-insert positioning. Six of the seven patients with a failed procedure, (85.7%) did not have suction curettage performed after NS-GEA. Proper micro-insert placement was documented by hysterosalpingography (21/80; 26.3%), ultrasound (56/80; 70%), or pelvic X-ray (3/80; 3.7%). When the ultrasound was not conclusive, hysterosalpingography was also performed for definitive confirmation. If hysterosalpingography was the initial confirmation test and showed inconclusive findings, ultrasound was performed. The three cases in which pelvic X-ray was used as the only follow-up test were the earliest cases in the study; at that time, pelvic X-ray was thought to provide sufficient evidence for confirmation of proper micro-insert placement. Intrauterine synechiae (5/87; 5.7%), endometritis (2/87; 2.3%), pain that required an emergency room visit (2/87; 2.3%), and migration of micro-inserts with or without perforation (4/87; 4.6%) were the short and long-term procedure complications. The uterine cavity after NS-GEA was not occluded in most cases in which hysterosalpingography was performed (16/21; 76.2%). 364 APRIL JOGC AVRIL 2011
5 Concomitant NovaSure Endometrial Ablation and Essure Tubal Sterilization: A Review of 100 Cases DISCUSSION This is the first study to clearly show the feasibility, efficacy, and safety of moving this procedure from the operating theatre to an outpatient, ambulatory setting, completely independent from day surgery and anaesthesia services. Previously published studies have proven that performing the Essure procedure in an ambulatory setting results in a statistically significant cost saving when compared with traditional laparoscopic tubal sterilization performed in the operating room. 17 Thus, we would expect to find similar savings when comparing the combined procedure performed in an outpatient, ambulatory setting with the combined procedure performed in the operating theatre. The device costs were covered for all patients by their provincial health care insurance. Our results agree with previously published studies reporting that concomitant NS-GEA and EHS is a generally safe, fast, and efficient method of providing both treatment for abnormal uterine bleeding and permanent female sterilization. 11,12 Furthermore, recent data have shown that placement of Essure micro-inserts does not alter the ability to perform subsequent NovaSure ablation, supporting acceptable safety profiles for NovaSure following Essure placement. 18 Unlike previously published studies, 11,12 our study assesses the success rate, complications and technical difficulties of concomitant NS-GEA and EHS in a much larger cohort of patients. We also report a shorter total procedure time of 17.1 ± 5.9 min (95% CI 15.9 to 18.3) (Table). Patients tolerated the combined procedure well with IV conscious sedation and post-procedure oral analgesia. Only one patient was too uncomfortable after the NS-GEA to allow subsequent EHS. Although this patient ultimately did not have the combined procedure, we opted to keep this case in our study to illustrate that the inability to perform EHS after NS-GEA because of the patient s discomfort is a rare but possible outcome. Uterine curettage and evacuation before endometrial ablation have been reported to improve post-ablation visualization of tubal ostia. 11 A subgroup of patients in our study had suction curettage after the NS-GEA, and this procedure did not significantly alter the procedure time. Therefore, in order to decrease the amount of postablation intrauterine debris, suction curettage should be considered before tubal sterilization. We encountered the following three types of technical difficulties in our study. Because these technical difficulties do not commonly occur when the procedures are performed individually, they are likely the result of combining the two procedures. 1. Impaired tubal visualization. This was the most common technical difficulty encountered in our study and was also reported by previous studies. 11,12 Although we were still able to cannulate tubal ostia in most patients in whom tubal visualization was impaired, we observed that two of these patients were among the seven cases with failed tubal sterilization. One of these two patients was also found to have a bicornuate uterus, and this might have added to the technical challenge of the combined procedure. 2. Impaired visualization and/or impaired counting of the number of intrauterine Essure micro-inserts placed. This was due to the uterine debris resulting from the endometrial ablation. This occurred in three cases, but in all three bilateral proper micro-insert placement was confirmed at the three-month follow-up. 3. Resistance met at micro-insert placement. This could have been related to tubal spasm or previous tubal scarring. In all three patients in whom this problem occurred, the confirmatory test showed proper microinsert placement at three months post procedure. The last two of these technical difficulties encountered during combined NS-GEA and EHS have not previously been reported, most likely because of the small number of cases analyzed in prior studies. Seven patients did not meet the criteria for proper positioning of micro-inserts or bilateral tubal occlusion. The patient who was shown to have a bicornuate uterus and who had technical difficulties at the time of the procedure also developed bilateral displacement of microinserts in the uterine cavity. This suggests that patients with an identified uterine anomaly might not be ideal candidates for a combined NS-GEA and EHS procedure, already described as more technically challenging. 11,19 Another patient with failed proper micro-insert positioning was among the cases in whom we encountered poor visualization of the ostia during the procedure. In one case we were not able to cannulate one ostium. In the remaining four cases, no obvious technical difficulties or complications were documented; this might also be explained by the reported increase in the difficulty of the combined procedures, 11,19 especially related to poor visualization of the ostia. A previous study, 11 however did not report that poor visualization of the ostia after APRIL JOGC AVRIL
6 endometrial ablation interfered with the success rate of the combined procedure. This difference might be explained by the smaller number of patients studied. All patients with failed micro-insert placement or tubal occlusion underwent subsequent laparoscopic tubal ligation or successfully repeated EHS. Intrauterine synechiae, endometritis, pain requiring a visit to the emergency room, and micro-insert migration and/ or perforation were the short- and long-term postoperative complications observed in this study. The formation of intrauterine synechiae was found to be the most common post-procedure complication. Also described in prior studies, this problem was not previously observed to interfere with determining the location of micro-inserts or occlusion of tubes. 11 This was not the case in our study, considering that in three out of the five patients diagnosed with uterine synechiae, the hysterosalpingogram failed to demonstrate tubal occlusion because of an inability to cannulate or properly fill the uterine cavity with contrast substance. However, we were able to confirm the proper placement of the device in these cases by ultrasound. Other complications included significant pain requiring a visit to the emergency room (two patients) or infection (two patients), suggesting a possible beneficial role of post-procedure prophylactic antibiotics. This subject is still controversial, and there is no evidence for or against the routine use of antibiotics. 19 We did not administer antibiotics in this study. However, other authors reported routine prophylactic use of antibiotic. 19 Three of the four patients found to have micro-insert migration/perforation at the three-month follow-up test were determined to have bilateral tubal occlusion on hysterosalpingography. Therefore, micro-insert migration does not necessarily imply tubal patency. CONCLUSION This study concludes that concomitant NS-GEA and ESH is a safe, fast, and efficient method of providing treatment for abnormal uterine bleeding and permanent female sterilization in an outpatient setting, completely independent of anaesthesia and day surgery services. Difficulty in visualizing the tubal ostia after the NS-GEA was the most common technical challenge encountered and might have interfered with proper visualization and placement of Essure devices. Suction curettage improved visualization of the ostia after GEA and did not significantly alter the procedure time; it should therefore be considered before performing tubal sterilization. A small proportion of patients developed post-procedure intrauterine synechiae that impaired the ability to document tubal occlusion by hysterosalpingography, but not by ultrasound. ACKNOWLEDGEMENTS Dr Thiel is a consultant with Conceptus, Inc. REFERENCES 1. Duckitt K. Managing perimenopausal menorrhagia. Maturitas 2010;66: Coulter A, Peto V, Jenkinson C. Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract 1994;11: Gallinat A. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients. Am J Obstet Gynecol 2004;191: Hare AA, Olah KS. Pregnancy following endometrial ablation: a review article. J Obstet Gynaecol 2005;25: Lo JS, Pickersgill A. Pregnancy after endometrial ablation: English literature review and case report. J Minim Invasive Gynecol 2006;13: Hoffman MK, Sciscione AC. Placenta accreta and intrauterine fetal death in a woman with prior endometrial ablation: a case report. J Reprod Med 2004;49: Laberge PY. Serious and deadly complications from pregnancy after endometrial ablation: two case reports and review of the literature. J Gynecol Obstet Biol Reprod (Paris) 2008;37: Kerin JF, Cooper JM, Price T, Herendael BJ, Cayuela-Font E, Cher D, et al. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study. Hum Reprod 2003;18: Kerin JF, Munday DN, Ritossa MG, Pesce A, Rosen D. Essure hysteroscopic sterilization: results based on utilizing a new coil catheter delivery system. J Am Assoc Gynecol Laparosc 2004;11: Cooper JM, Carignan CS, Cher D, Kerin JF. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol 2003;102: Hopkins MR, Creedon DJ, El-Nashar SA, Brown DL, Good AE, Famuyide AO. Radiofrequency global endometrial ablation followed by hysteroscopic sterilization. J Minim Invasive Gynecol 2007;14: Donnadieu AC, Deffieux X, Gervaise A, Faivre E, Frydman R, Fernandez H. Essure sterilization associated with endometrial ablation. Int J Gynaecol Obstet 2007;97(2): Thiel JA, Suchet IB, Lortie K. Confirmation of Essure microinsert tubal coil placement with conventional and volume-contrast imaging threedimensional ultrasound. Fertil Steril 2005;84: Kerin JF, Carignan CS, Cher D. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure PBC clinical study. Aust N Z J Obstet Gynaecol 2001;41: Weston G, Bowditch J. Office ultrasound should be the first-line investigation for confirmation of correct ESSURE placement. Aust N Z J Obstet Gynaecol 2005;45(4): Veersema S, Vleugels MP, Timmermans A, Brolmann HA. Follow-up of successful bilateral placement of Essure microinserts with ultrasound. Fertil Steril 2005;84: Thiel JA, Carson GD. Cost-effectiveness analysis comparing the Essure tubal sterilization procedure and laparoscopic tubal sterilization. J Obstet Gynaecol Can 2008;30: Coad JE, Garza-Leal J, Castillo-Saenz L, Hernandez-Leon I, Livengood RH. Essure permanent birth control followed by global endometrial ablation: an in vivo peri-hysterectomy study. J Minim Invasive Gynecol 2010;17:S Donnadieu AC, Fernandez H. The role of Essure sterilization performed simultaneously with endometrial ablation. Curr Opin Obstet Gynecol 2008;20: APRIL JOGC AVRIL 2011
The development of new medical technology invariably
Cost-Effectiveness Analysis Comparing the Essure Tubal Sterilization Procedure and Laparoscopic Tubal Sterilization John A. Thiel, MD, George D. Carson, MD Department of Obstetrics and Gynecology, Regina
More informationUnintended pregnancies after Essure sterilization in the Netherlands
Unintended pregnancies after Essure sterilization in the Netherlands S. Veersema M.P.H. Vleugels L.M. Moolenaar C.A.H. Janssen H.A.M. Brölmann Fertil Steril. 2010;93:35-8. 13 Hysteroscopic Sterilization
More informationClinical Experience With Contrast Infusion Sonography as an Essure Confirmation Test
ORIGINAL RESEARCH Clinical Experience With Contrast Infusion Sonography as an Essure Confirmation Test Viviane F. Connor, MD Received November 3, 2010, from the Department of Gynecology, Section of Minimally
More informationMEDICAL POLICY SUBJECT: FEMALE STERILIZATION. POLICY NUMBER: CATEGORY: Contract Clarification
MEDICAL POLICY SUBJECT: FEMALE STERILIZATION PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationFemale sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation
BJOG: an International Journal of Obstetrics and Gynaecology November 2005, Vol. 112, pp. 1522 1528 DOI: 10.1111/j.1471-0528.2005.00726.x Female sterilisation: a cohort controlled comparative study of
More informationComplications of hysteroscopic Essure â sterilisation: report on 4306 procedures performed in a single centre
DOI: 10.1111/j.1471-0528.2012.03292.x www.bjog.org Fertility control Complications of hysteroscopic Essure â sterilisation: report on 4306 procedures performed in a single centre B Povedano, a JE Arjona,
More informationNational Institute for Health and Clinical Excellence
National Institute for Health and Clinical Excellence 218_2 Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants Consultation Comments table IPAC date: Thursday 16
More informationMyometrial Insertion of Essure Mirco-Insert
Case Report http://www.alliedacademies.org/research-and-reports-in-gynecology-and-obstetrics Myometrial Insertion of Essure Mirco-Insert Jeffrey J Woo 1*, Barbara E Simpson 1, Dale W Stovall 2 1 Department
More informationSatisfaction and tolerance with office hysteroscopic tubal sterilization
TECHNIQUES AND INSTRUMENTATION Satisfaction and tolerance with office hysteroscopic tubal sterilization Jose E. Arjona, M.D., Ph.D., a Monica Mi~no, M.D., Ph.D., a Javier Cordon, M.D., Ph.D., a Balbino
More informationEssure By Mayo Clinic staff
Page 1 of 5 Reprints A single copy of this article may be reprinted for personal, noncommercial use only. Essure By Mayo Clinic staff Original Article: http://www.mayoclinic.com/health/essure/my00999 Definition
More informationESSURE A RESOURCE FOR CODING
ESSURE REIMBURSEMENT GUIDE A RESOURCE FOR CODING INDICATION Essure is indicated for women who desire permanent birth control (female sterilization) by bilateral occlusion of fallopian tubes. IMPORTANT
More informationINTERVENTIONAL PROCEDURES PROGRAMME
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of microwave endometrial ablation Introduction This overview has been prepared to assist
More informationENDOMETRIAL ABLATION: TRENDS AND CHALLENGES IN 2017
ENDOMETRIAL ABLATION: TRENDS AND CHALLENGES IN 2017 Philippe Laberge MD FRCSC ACGE Professor Obstetrics and Gynecology Laval University Quebec, Canada Disclosures I have used products or done clinical
More informationExcessive menstrual blood loss
Ian Chilcott Excessive menstrual blood loss >80mls - That interferes with physical, emotional, social and material quality of life 1 in 20 women aged 30 to 49 years consult their GP each year with menorrhagia
More informationSIMPLE SAFE EFFECTIVE. Your Solution to Outpatient Ablation
SIMPLE SAFE EFFECTIVE Your Solution to Outpatient Ablation WWW.THERMABLATE-EAS.COM SIMPLE Unique, fully automated design continually controls parameters of time, temperature and pressure to ensure consistent
More informationProbability of pregnancy after sterilization: a comparison of hysteroscopic versus laparoscopic sterilization,
Contraception xx (2014) xxx xxx Original research article Probability of pregnancy after sterilization: a comparison of hysteroscopic versus laparoscopic sterilization, Aileen M. Gariepy a,, Mitchell D.
More informationCOMPARING THE EFFICACY AND ACCEPTABILITY OF NOVASURE TM VERSUS CAVATERM TM PLUS IN DUB PATIENTS
: 1035-1045 ISSN: 2277 4998 COMPARING THE EFFICACY AND ACCEPTABILITY OF NOVASURE TM VERSUS CAVATERM TM PLUS IN DUB PATIENTS ZAHRA ASGARI 1, M.D., LEILI HAFIZI 2, M.D., FARIDEH HOSSEINZADEH 3, M.D., AZAM
More informationV. Mijatovic S. Veersema M.H. Emanuel R. Schats P.G. Hompes. Fertil Steril. 2010;93:
Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. V. Mijatovic S. Veersema
More informationRole of diagnostic hysteroscopy in evaluation of abnormal uterine bleeding and its histopathological correlation
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Chaudhari KR et al. Int J Reprod Contracept Obstet Gynecol. 2014 Sep;3(3):666-670 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationHysteroscopy - current trends and challenges
J Obstet Gynecol India Vol. 58, No. 1 : January/February 2008 pg 57-62 Original Article Hysteroscopy - current trends and challenges Gour A, Zawiejska A, Mettler L Department of Obstetrics and Gynaecology,
More informationEssure Permanent Birth Control Device: Radiological followup results at our center
Essure Permanent Birth Control Device: Radiological followup results at our center Poster No.: C-0212 Congress: ECR 2013 Type: Scientific Exhibit Authors: R. Díaz Aguilera, A. M. Higuera Higuera, V. Palomo
More informationFemale sterilization by the natural pathways
info-canada@conceptus.com www.essure.com Female sterilization by the natural pathways magazine 1.Hatcher R et al. Contraceptive Technology, 17 th Edition. New York : Ardent Media, 1998. 2. Bhiwandiwala
More informationEvidence Based Guideline Intrauterine Ablation or Resection of the Endometrium
Evidence Based Guideline Intrauterine Ablation or Resection of the Endometrium File Name: intrauterine_ablation_or_resection_of_the_endometrium Guideline Number: EBG.OBGYN3030 Origination: 4/1993 Last
More information= 0.002) 117 #!. 12, : = 0.45; P
Background: Psychosocial factors governing the use of postoperative, intravenous patient-controlled analgesia (PCA) have received little attention in spite of the fact that PCA is the most common modality
More informationUpdate on the Essure System for Permanent Birth Control
Update on the Essure System for Permanent Birth Control Heidi Collins Fantasia IIn 2002, the U.S. Food and Drug Administration (FDA) approved Essure (Bayer, Whippany, NJ), a minimally invasive procedure
More informationTranscervical Sterilization
Q UESTIONS & ANSWERS A BOUT Transcervical Sterilization A New Choice in Permanent Birth Control Choosing a Birth Control Method Women and their partners now have more birth control choices than ever. How
More informationbleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the
Studies on the diagnosis of endometria cancer in women with postmenopausal bleeding. Studies naar de diagnostiek va endometriumcarcinoom bij vrouwen m postmenopauzaal bloedverlies. Studies on the diagnosis
More informationMyometrial scoring: a new technique for the management of severe Asherman s syndrome
FERTILITY AND STERILITY VOL. 69, NO. 5, MAY 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Myometrial scoring: a
More informationClinical Predictors of Endometriosis in the Infertility Population: Is There a Better Way to Determine Who Needs a Laparoscopy?
Gynaecology Clinical Predictors of Endometriosis in the Infertility Population: Is There a Better Way to Determine Who Needs a Laparoscopy? Kellie Whitehill, MD, FRCSC, 1 Paul J. Yong, MD, PhD, FRCSC,
More informationMicroinsert Nonincisional Hysteroscopic Sterilization
Microinsert Nonincisional Hysteroscopic Sterilization Jay M. Cooper, MD, Charles S. Carignan, MD, Daniel Cher, MD, and John F. Kerin, MD, for the Selective Tubal Occlusion Procedure 2000 Investigators
More informationMenstrual Disorders & Ambulatory Gynaecology
Menstrual Disorders & Ambulatory Gynaecology Mr. Nagui Lewis Aziz M B, CH B, FRCOG Consultant Gynaecologist The Royal Oldham Hospital 01/09/2018 Heavy menstrual bleeding (HMB ) is a common problem responsible
More informationFertility Treatment Decision-Making: The Effect of Insurance Coverage for Fertility Medications
GYNAECOLOGY Fertility Treatment Decision-Making: The Effect of Insurance Coverage for Fertility Medications Claire Ann Jones, MD, 1 Laura Gra, hd, 2 Kimberl Liu, MD, FRCSC, MSL 1,3 1 Department of Obstetrics
More informationCorporate Medical Policy
Corporate Medical Policy Intrauterine Ablation or Resection of the Endometrium File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intrauterine_ablation_or_resection_of_the_endometrium
More informationLaparoscopy-Hysteroscopy
Laparoscopy-Hysteroscopy Patient Information Laparoscopy The laparoscope, a surgical instrument similar to a telescope, is inserted through a small incision (cut) in the belly button during laparoscopy.
More information1000 Office-Based Hysteroscopies Prior to In Vitro Fertilization: Feasibility and Findings
SCIENTIFIC PAPER 1000 Office-Based Hysteroscopies Prior to In Vitro Fertilization: Feasibility and Findings Mary D. Hinckley, MD, Amin A. Milki, MD ABSTRACT Background and Objectives: Hysteroscopy offers
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationAn Overview of Uterine Factors That Influence Implantation
An Overview of Uterine Factors That Influence Implantation Bulent Urman, M.D. Dept. of Obstetrics and Gynecology Koc University School of Medicine Assisted Reproduction Unit, American Hospital, ISTANBUL
More informationYour visit to the Outpatient Hysteroscopy Clinic
Your visit to the Outpatient Hysteroscopy Clinic Department of Gynaecology Patient Information What What is the is an Outpatient outpatient Cystoscopy hysteroscopy? Clinic? An outpatient hysteroscopy means
More informationAileen M. CON-08309; No of Pages 8. Contraception xx (2014) xxx xxx
CON-08309; No of Pages 8 1 Original research article 2 Probability of pregnancy after sterilization: a comparison of hysteroscopic 3 versus laparoscopic sterilization, 4Q1 Aileen M. 5 6 7 Contraception
More informationChapter 7 Infertility, Contraception, and Abortion
Chapter 7 Infertility, Contraception, and Abortion Infertility Incidence Affects about 10% to 15% of reproductive-age population Subfertility: prolonged time to conceive Sterility: inability to conceive
More informationMENSTRUAL PATTERNS AND WOMEN'S ATTITUDES FOLLOWING STERILIZATION BY FA LOPE RINGS*
FERTILITY AND STERILITY Copyright 1979 The American Fertility Society Vol. 31, No.6, June 1979 Printed in U.s.A. MENSTRUAL PATTERNS AND WOMEN'S ATTITUDES FOLLOWING STERILIZATION BY FA LOPE RINGS* LIDIA
More informationOutpatient hysteroscopy direct diagnostic access & new therapeutic procedures
Outpatient hysteroscopy direct diagnostic access & new therapeutic procedures Mrs Katy Clifford Consultant Gynaecologist St Mary s Hospital Imperial College Healthcare NHS Trust Diagnostic outpatient hysteroscopy
More informationPermanent Sterilization: When you are really sure!
Permanent Sterilization: When you are really sure! Tony Ogburn MD Department of Ob/Gyn 2006-8 National Survey of Family Growth 6.1% of women had a sterilized male partner The History of Female Sterilization
More informationCase Report Essure Surgical Removal and Subsequent Resolution of Chronic Pelvic Pain: A Case Report and Review of the Literature
Case Reports in Obstetrics and Gynecology Volume 2016, Article ID 6961202, 5 pages http://dx.doi.org/10.1155/2016/6961202 Case Report Essure Surgical Removal and Subsequent Resolution of Chronic Pelvic
More informationOne-step transvaginal three-dimensional hysterosalpingofoam sonography (3D-HyFoSy) confirmation test for Essure follow-up: a multicenter study
Ultrasound Obstet Gynecol 2018; 51: 134 141 Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.17398 One-step transvaginal three-dimensional hysterosalpingofoam sonography
More informationClinical Policy: Essure Removal Reference Number: CP.MP.131
Clinical Policy: Reference Number: CP.MP.131 Effective Date: 11/16 Last Review Date: 11/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationHeavy Menstrual Bleeding. Mr Nick Nicholas MD FRCOG Grad Dip Law. Consultant Gynaecologist
Heavy Menstrual Bleeding Mr Nick Nicholas MD FRCOG Grad Dip Law. Consultant Gynaecologist Why is HMB so important? 1:20 women aged 30-49 consult their GP with HMB Once referred to gynaecologist, surgical
More informationCOLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS, SINGAPORE 2006
COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS, SINGAPORE 2006 CONSENSUS STATEMENT ON THE MANAGEMENT AND EVALUATION OF MENORRHAGIA (INCLUDING MANAGEMENT OF FIBROIDS) Introduction Menorrhagia is defined as
More informationHysteroscopic Tubal Sterilization: An Evidence-Based Analysis
Hysteroscopic Tubal Sterilization: An Evidence-Based Analysis K McMartin October 2013 Ontario Health Technology Assessment Series; Vol.13: No. 21, pp. 1 35, October 2013 Suggested Citation This report
More informationDiagnostic Features and Therapeutic Consequences of Hysteroscopy in Women with Abnormal Uterine Bleeding and Abortion
American Journal of Applied Sciences 9 (1): 13-17, 2012 ISSN 1546-9239 2012 Science Publications Diagnostic Features and Therapeutic Consequences of Hysteroscopy in Women with Abnormal Uterine Bleeding
More informationHysterectomy : A Clinicopathologic Correlation
Bahrain Medical Bulletin, Vol. 28, No.2, June 2006 Hysterectomy : A Clinicopathologic Correlation Layla S Abdullah, FRCPC* Objective : To study the most common pathologies identified in hysterectomy specimens
More informationTHE WOMAN-FRIENDLY STERILIZATION METHOD
THE WOMAN-FRIENDLY STERILIZATION METHOD Urogyn BV Transistorweg 5a 6534 AT Nijmegen The Netherlands t +31(0) 24 711 41 30 info@urogynbv.com www.urogynbv.com THE MOST WOMAN-FRIENDLY STERILIZATION METHOD
More informationASHERMAN S SYNDROME FOLLOWING THERMAL ABLATION OF THE ENDOMETRIUM Sheila K. Pillai 1, Bhuvana S 2, Jaya Vijayaraghavan 3
ASHERMAN S SYNDROME FOLLOWING THERMAL ABLATION OF THE ENDOMETRIUM Sheila K. Pillai 1, Bhuvana S 2, Jaya Vijayaraghavan 3 HOW TO CITE THIS ARTICLE: Sheila K. Pillai, Bhuvana S, Jaya Vijayaraghavan. Asherman
More informationAdvanced 3D Ultrasound Incorporating Fly Thru Virtual Imaging Promotes the Concept of Ultrasound Hysteroscopy
Advanced 3D Ultrasound Incorporating Fly Thru Virtual Imaging Promotes the Concept of Ultrasound Hysteroscopy Bill Smith Clinical Diagnostics Services, London, UK Introduction Conventional hysteroscopy
More informationVirtaMed GynoS hysteroscopy Module descriptions
VirtaMed GynoS hysteroscopy Module descriptions VirtaMed AG Rütistr. 12, 8952 Zurich Switzerland info@virtamed.com www.virtamed.com Phone: +41 44 500 9690 Table of contents Table of contents... 1 Essential
More informationIndian Journal of Basic and Applied Medical Research; September 2015: Vol.-4, Issue- 4, P
Original article: To study post intrauterine insemination conception rate among infertile women with polyp and women with normal uterine endometrium cavity 1Dr. Archana Meena, 2 Dr. Renu Meena, 3 Dr. Kusum
More informationColposcopic Episodes of Care: Referral, Treatment, Follow-Up, and Exit Patterns of Care for Women With Abnormal Pap Smears
GYNAECOLOGY Colposcopic Episodes of Care: Referral, Treatment, Follow-Up, and Exit Patterns of Care for Women With Abnormal Pap Smears Rachel Kupets, MD, 1 Yan Lu, MSc, 2 Danielle Vicus, MD, 1 Lawrence
More informationDoes Laparoscopy Safely Improve Technicity for Complex Hysterectomy Cases?
GYNAECOLOGY Does Laparoscopy Safely Improve Technicity for Complex Hysterectomy Cases? Amanda Grant-Orser, BSc, 1 Ramadan El Sugy, MD, 1,2 Sukhbir S. Singh, MD, FRCSC 1,2,3 1 Department of Obstetrics and
More informationRANZCOG Advanced Training Modules
RANZCOG Advanced Training Modules Generalist Obstetrics ATM and Generalist Gynaecology ATM The Generalist ATMs in each of Obstetrics and Gynaecology provide a framework for trainees to consolidate and
More informationLaparoscopy and Hysteroscopy
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Laparoscopy and Hysteroscopy A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of
More informationM-AFRAKHTEH. MD OCT.2017 SHOHADA HOSPITAL TAJRISH
Unrestricted M-AFRAKHTEH. MD OCT.2017 SHOHADA HOSPITAL TAJRISH Patients at imminent risk of exsanguination Manual aortic compression Resuscitative endovascular balloon occlusion of the aorta Uterine tourniquet
More informationSURGICAL PROBLEMS IN FERTILITY- FIBROIDS. Dr.Māris Arājs gyn-ob specialist Cell phone:
SURGICAL PROBLEMS IN FERTILITY- FIBROIDS Dr.Māris Arājs gyn-ob specialist maris@myclinicriga.lv Cell phone: +371 26556466 There is NO Industry Sponsorship and Financial Conflict of Interest for this presentation
More informationSurgery and Infertility
Surgery and Infertility Dr Phill McChesney BHB MBChB FRANZCOG MRMed CREI Laparoscopy Prior to Considering IVF Diagnostic Tubal Surgery Treatment of peritubal adhesions Reconstructive surgery Sterilization
More informationEndometrial Ablation. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Endometrial Ablation Page: 1 of 10 Last Review Status/Date: December 2012 Endometrial Ablation
More informationHIGH-DEFINITION HYSTEROSCOPY FOR A HIGH STANDARD OF CARE.
HIGH-DEFINITION HYSTEROSCOPY FOR A HIGH STANDARD OF CARE. Our next-generation TruClear hysteroscopes were designed with your technique and the patient experience in mind TruClear Elite Hysteroscope Mini
More informationTUBAL PLASTIC SURGERY is an accepted form of therapy in the treatment
Tubal Plastic Surgery ADNAN MROUEH, M.D., ROBERT H. GLASS, M.D., and C. LEE BUXTON, M.D. TUBAL PLASTIC SURGERY is an accepted form of therapy in the treatment of infertility. However, reports have differed
More informationLaparoscopic Versus Abdominal Myomectomy: Practice Patterns and Health Care Use in British Columbia
GYNAECOLOGY Laparoscopic Versus Abdominal Myomectomy: Practice Patterns and Health Care Use in British Columbia Innie Chen, MD, FRCSC, 1,2 Sarka Lisonkova, MD, PhD, 3 K.S. Joseph, MD, PhD, 2,3 Christina
More informationMEDICAL POLICY SUBJECT: ENDOMETRIAL ABLATION
MEDICAL POLICY PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.
More informationLabeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization Draft Guidance for Industry and Food and Drug
More informationExample CLINICAL GUIDELINES for Postpartum IUD insertion
Example CLINICAL GUIDELINES for Postpartum IUD insertion Postpartum Intrauterine Device Insertion 1.0 Indications: 1.1 Insertion of an intrauterine device (IUD) for long-acting reversible contraception
More informationThe Role of Appendectomy in Gynaecologic Surgery: A Canadian Retrospective Case Series
GYNAECOLOGY The Role of Appendectomy in Gynaecologic Surgery: A Canadian Retrospective Case Series Jennifer A. Jocko, BScN, MD, Hassan Shenassa, MD, FRCSC, Sukhbir S. Singh, MD, FRCSC Department of Obstetrics
More informationPrediction of Treatment Outcomes After Global Endometrial Ablation. Excessive menstrual bleeding is a common problem
Prediction of Treatment Outcomes After Global Endometrial Ablation Sherif A. El-Nashar, MBBCh, MS, Matthew R. Hopkins, MD, Douglas J. Creedon, MD, PhD, Jennifer L. St. Sauver, PhD, Amy L. Weaver, MS, Michaela
More informationFigure 1b: Essure Insert (NOT TO SCALE) (NOT TO SCALE)
Figure 1b: Essure Insert Expanded configuration, detached from the delivery system (NOT TO SCALE) WARNING: Some patients implanted with the Essure System for Permanent Birth Control have experienced and/or
More informationNot all roads point to hysterectomy: treatment options for fibroids
Not all roads point to hysterectomy: treatment options for fibroids MAUREEN KOHI, MD DEPARTMENT OF RADIOLOGY JEANNETTE LAGER, MD DEPARTMENT OF OBSTETRICS, GYNECOLOGY AND REPRODUCTIVE SCIENCES A lady, recently
More informationChapter 2. Implementation of hysteroscopic surgery in The Netherlands. Heleen van Dongen Wendela Kolkman Frank Willem Jansen
Chapter 2 Implementation of hysteroscopic surgery in The Netherlands Heleen van Dongen Wendela Kolkman Frank Willem Jansen Adapted from Eur J Obstet Gynecol Reprod Biol 07;132:232-236 Introduction Diagnostic
More informationRetrospective Review of Predisposing Factors and Surgical Outcomes in Obstetric Fistula Patients at a Single Teaching Hospital in Western Kenya
GYNAEcOLOGY Retrospective Review of Predisposing Factors and Surgical Outcomes in Obstetric Fistula Patients at a Single Teaching Hospital in Western Kenya Erin McFadden, MD, 1 Sarah Jane Taleski, MHSc,
More informationHysteroscopic Essure Inserts for Permanent Contraception Extended Follow-up Results of a Phase III, Multicenter, International Study
Accepted Manuscript Hysteroscopic Essure Inserts for Permanent Contraception Extended Follow-up Results of a Phase III, Multicenter, International Study Scott G. Chudnoff, MD, MS, John E. Nichols, Jr.,
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of sterilisation by insertion of intrafallopian implants Sterilisation is sometimes
More informationFemale Sterilization. Kavita Nanda, MD, MHS FHI 360 Expanding Contraceptive Choice December 6, 2018
Female Sterilization Kavita Nanda, MD, MHS FHI 360 Expanding Contraceptive Choice December 6, 2018 What is female sterilization? Family planning method that provides permanent contraception to women and
More informationGLOBAL ENDOMETRIAL ABLATION TECHNOLOGY
GLOBAL ENDOMETRIAL ABLATION TECHNOLOGY Training: Part 1 Anatomy and Physiology Female Anatomy Normal Uterus Female Anatomy Normal Uterus Female Anatomy Uterine Positions Abnormal Uterus Retroflexed Normal
More informationCHAPTER 13 Gynaecological Procedures
CHAPTER 13 Propunere noua clasificare proceduri folosind codificarea ICD-10-AM versiunea 3, 30 martie 2004 Gynaecological Procedures BLOCK 1240 Application, insertion or removal procedures on ovary 35518-00
More informationREPRODUCTIVE ENDOCRINOLOGY
REPRODUCTIVE ENDOCRINOLOGY FERTILITY AND STERILITY VOL. 82, NO. 1, JULY 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Treatment
More informationFamily Planning Eligibility Program
INDIANA HEALTH COVERAGE PROGRAMS PROVIDER REFERENCE M ODULE Family Planning Eligibility Program L I B R A R Y R E F E R E N C E N U M B E R : P R O M O D 0 0 0 5 3 P U B L I S H E D : N O V E M B E R 2
More informationNational inpatient diagnostic hysteroscopy survey
Gynecol Surg (2010) 7:53 59 DOI 10.1007/s10397-009-0508-0 CLINICAL PRACTICE National inpatient diagnostic hysteroscopy survey Sherif Tawfeek & Peter Scott Received: 21 June 2009 /Accepted: 9 July 2009
More informationINTERVENTIONAL PROCEDURES PROGRAMME
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of balloon thermal endometrial ablation (Cavaterm) Introduction This overview has been prepared
More informationHysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study*
Human Reproduction Vol.18, No.6 pp. 1223±1230, 2003 DOI: 10.1093/humrep/deg256 Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study* John F.Kerin 1,8, Jay M.Cooper
More informationFigure 1b: Essure Insert (NOT TO SCALE)
Figure 1b: Essure Insert Expanded configuration, detached from the delivery system (NOT TO SCALE) WARNING: Some patients implanted with the Essure System for Permanent Birth Control have experienced and/or
More informationEvaluation of the Infertile Couple
Overview and Definition Infertility is defined as the inability of a couple to fall pregnant after one year of unprotected intercourse. Infertility is a very common condition as in any given year about
More informationAbnormal uterine bleeding:
Primary Care Women s Health Forum 16th June 2010 Abnormal uterine bleeding: The University Of Birmingham T Justin Clark MD (Hons), MRCOG Consultant Obstetrician and Gynaecologist Birmingham Women s Hospital
More informationPALM-COEIN: Your AUB Counseling Guide
PALM-COEIN: Your AUB Counseling Guide 10 million+ Treat the cause, not the symptom In the U.S, more than 10 million women between the ages of 35 and 49 are affected by AUB 1 Diagnosis Cause Structural
More informationSubject Index. Cavaterm, endometrial ablation complications 146, 150 contraindications 152 cost analysis compared with hysterectomy
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index Abnormal uterine bleeding, see also Adenomyosis, Endometrial cancer, Menorrhagia dilatation and curettage 21, 22, 25 hysteroscopy of premenopausal women anesthesia
More informationImaging evaluation of gynaecological devices
Imaging evaluation of gynaecological devices Poster No.: C-0850 Congress: ECR 2013 Type: Educational Exhibit Authors: R. M. Lorente Ramos, J. Azpeitia Arman, P. Aparicio Rodríguez- 1 1 1 1 1 Miñón, F.
More informationSTOP/START. On the Web. 12 intraoperative videos from Dr. Garcia, at
Diagnostic hysteroscopy spies polyp previously missed on transvaginal ultrasound and dilation and curettage. STOP performing dilation and curettage for the evaluation of abnormal uterine bleeding START
More informationRoutine vaginoscopic office hysteroscopy in modern infertility work-up: a randomized controlled trial
Gynecol Surg (2014) 11:185 189 DOI 10.1007/s10397-014-0840-x ORIGINAL ARTICLE Routine vaginoscopic office hysteroscopy in modern infertility work-up: a randomized controlled trial Atef M. Darwish & Ahmad
More informationEndometrial Ablation. Description
Subject: Endometrial Ablation Page: 1 of 12 Last Review Status/Date: September 2016 Endometrial Ablation Description Endometrial ablation is a potential alternative to hysterectomy for abnormal uterine
More informationOffice hysteroscopy offers many benefits
MINIMALLY INVASIVE GYNECOLOGY How to reduce patient anxiety and pain during in-office hysteroscopy Amy L. Garcia, MD Dr. Garcia is Director, Center for Women s Surgery and Garcia Institute for Hysteroscopic
More informationSurgical Privileges Form: Obstetrics & Gynecology
Surgical Privileges Form: Obstetrics & Gynecology Applicant s Name:. License No. (If Any):... Clinical Privileges Request Scope of Practice:. Facility:.. Date:... Privileges Requested (To be completed
More informationEndometrial ablation was developed as a uterinesparing
Minimally Invasive Device Complications and Use Outside of the Manufacturers Instructions Jill Brown, MD, MPH, and Ken Blank, MD OBJECTIVE: To review the U.S. Food and Drug Administration (FDA) Manufacturer
More informationIs Outpatient Hysteroscopy the New Gold Standard?
Is Outpatient Hysteroscopy the New Gold Standard? McIlwaine K, Readman E, Ma T, Manwaring J, Ellett L, Hicks L, Porter J, Cameron M, Maher P. Mercy Hospital for Women, Melbourne, Australia Background Abnormal
More information